|
MCM2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.02240000021681E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.50179999999223E-05 |
| Normal-vs-Stage2 |
6.881700E-02 |
| Normal-vs-Stage3 |
1.217330E-04 |
| Normal-vs-Stage4 |
1.75660999999216E-05 |
| Stage1-vs-Stage2 |
2.740600E-01 |
| Stage1-vs-Stage3 |
6.111800E-01 |
| Stage1-vs-Stage4 |
2.479500E-02 |
| Stage2-vs-Stage3 |
2.334000E-01 |
| Stage2-vs-Stage4 |
1.161720E-02 |
| Stage3-vs-Stage4 |
7.828400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65460000034479E-07 |
| Normal-vs-AfricanAmerican |
5.663700E-03 |
| Normal-vs-Asian |
1.858780E-01 |
| Caucasian-vs-AfricanAmerican |
9.595600E-01 |
| Caucasian-vs-Asian |
3.909400E-01 |
| AfricanAmerican-vs-Asian |
4.535600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.7157999999684E-06 |
| Normal-vs-Female |
5.5814999999626E-07 |
| Male-vs-Female |
4.371600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.678400E-03 |
| Normal-vs-Age(41-60Yrs) |
7.09170000501302E-08 |
| Normal-vs-Age(61-80Yrs) |
2.48019999999904E-05 |
| Normal-vs-Age(81-100Yrs) |
7.384600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.191200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.893220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.681600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.828000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.30169999999585E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.009600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.585910E-02 |
| Normal-vs-Grade 2 |
7.96929999999918E-05 |
| Normal-vs-Grade 3 |
1.56517999999606E-05 |
| Normal-vs-Grade 4 |
8.17430000000785E-05 |
| Grade 1-vs-Grade 2 |
1.602980E-01 |
| Grade 1-vs-Grade 3 |
3.411800E-01 |
| Grade 1-vs-Grade 4 |
5.375600E-01 |
| Grade 2-vs-Grade 3 |
3.828400E-01 |
| Grade 2-vs-Grade 4 |
1.606430E-02 |
| Grade 3-vs-Grade 4 |
4.064100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.083910E-03 |
| Normal-vs-ccB subtype |
2.33079999967245E-07 |
| ccA subtype-vs-ccB subtype |
4.880000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.13759999987151E-07 |
| Normal-vs-N1 |
1.277160E-03 |
| N0-vs-N1 |
1.375510E-03 |
|
|
